Castle Biosciences has a total of 87 patents globally, out of which 34 have been granted. Of these 87 patents, more than 58% patents are active. The USA is where Castle Biosciences has filed the maximum number of patents, followed by European Countries and Canada, it has generated an annual revenue of $94 million in the year 2021. Parallelly, China seems to be the main focused R&D centre of Castle Biosciences.
Castle Biosciences was founded in the year 2007 by Derek J. Maetzold. Company is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. As of August 2022, Castle Biosciences has a market cap of $814.84 million.
Do read about some of the most popular patents of Castle Biosciences which have been covered by us in this article and also you can find Castle Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Castle Biosciences patent portfolio.
How many patents does the founder and the CEO of Castle Biosciences have?
The founder and CEO, Derek J. Maetzold, has 10 patents.
How many patents does Castle Biosciences have?
Castle Biosciences has a total of 87 patents globally. These patents belong to 20 unique patent families. Out of 87 patents, 51 patents are active.
How Many Patents did Castle Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Castle Biosciences Applications Filed | Castle Biosciences Patents Granted |
| 2011 | – | 1 |
| 2012 | 12 | 2 |
| 2013 | 2 | 3 |
| 2014 | 13 | – |
| 2015 | 2 | 1 |
| 2016 | 11 | 2 |
| 2017 | 3 | – |
| 2018 | 1 | 4 |
| 2019 | 6 | 4 |
| 2020 | 5 | 5 |
| 2021 | 6 | 2 |
| 2022 | 1 | 4 |
How many Castle Biosciences patents are Alive/Dead?
How Many Patents did Castle Biosciences File in Different Countries?
Countries in which Castle Biosciences Filed Patents
| Country | Patents |
| United States Of America | 26 |
| Europe | 11 |
| Canada | 9 |
| Australia | 7 |
| Germany | 5 |
| Israel | 4 |
| Spain | 3 |
| Japan | 3 |
| Brazil | 2 |
| India | 2 |
| New Zealand | 1 |
| Singapore | 1 |
Where are Research Centres of Castle Biosciences Patents Located?
10 Best Castle Biosciences Patents
US6618679B2 is the most popular patent in the Castle Biosciences portfolio. It has received 285 citations so far from companies like Illumina, Integenx, and Gen-Probe.
Below is the list of 10 most cited patents of Castle Biosciences:
| Publication Number | Citation Count |
| US6618679B2 | 285 |
| US20080124726A1 | 156 |
| US20030204322A1 | 65 |
| US7824856B2 | 43 |
| US20060281108A1 | 22 |
| US7897750B2 | 19 |
| US8114615B2 | 8 |
| US8597899B2 | 7 |
| EP2636755A1 | 6 |
| WO2012178058A1 | 6 |
EXCLUSIVE INSIGHTS COMING SOON!
What are Castle Biosciences’ key innovation segments?
What Technologies are Covered by Castle Biosciences’?
The chart below distributes patents filed by Castle Biosciences’ in different countries on the basis of the technology protected in patents. It also represents the markets where Castle Biosciences’ thinks it’s important to protect particular technology inventions.
R&D Focus: How Castle Biosciences’ search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Castle Biosciences’?